TOP 30 Best Cancer immunotherapy research in Baltimore, Maryland

Evan Lipson, MD is a renowned institution specializing in skin cancer and immunotherapy treatment located at 401 North Broadway, Baltimore, Maryland, United States. Dr. Lipson is an internationally recognized specialist in cutaneous oncology and clinical immunotherapy at Johns Hopkins. He leads cutting edge clinical trials for patients with melanoma and other skin cancers, focusing on evaluating novel therapies for high-risk or advanced disease. Dr. Lipson's research has led to significant advancements in the field, including the development of relatlimab, an antibody blocking the LAG-3 immune checkpoint. Due to the recent collapse of the Francis Scott Key Bridge, patients are advised to anticipate delays when traveling to appointments at the Baltimore location. Masks are strongly recommended but not required in Maryland, following a downward trend in respiratory viruses. Dr. Lipson is also an educator in the field of cancer immunotherapy, providing lectures on immune-mediated drug toxicities associated with novel cancer drugs.

Khinh Voong, MD, MPH is a medical institution located at 4940 Eastern Avenue in Baltimore, Maryland, United States. Specializing in thoracic malignancies such as lung, esophageal, thymic cancers, and mesothelioma, Dr. K. Ranh Voong is the Program Director for the Radiation Oncology Residency Program. She treats patients at both the Johns Hopkins Thoracic Center of Excellence at Johns Hopkins Bayview and at the Proton Center at Sibley Memorial Hospital. Dr. Voong has extensive expertise in proton therapy, SBRT, IMRT for tumors involving the chest. She is involved in various research activities focused on improving the effectiveness of radiation therapy for patients with thoracic cancers. The institution strongly recommends wearing masks but it is not required in Maryland. Please anticipate delays when traveling to appointments due to the recent collapse of the Francis Scott Key Bridge in the Baltimore Region. For more information on the services offered by Khinh Voong, MD, MPH, please visit their website.

Dr. Tanguy Lim-Seiwert is a renowned oncologist located at 201 North Broadway in Baltimore, Maryland. He specializes in treating patients with head and neck cancer and serves as the director of the Head and Neck Cancer Oncology Disease Program at Johns Hopkins School of Medicine. Dr. Seiwert received his medical degree from Johannes Gutenberg Universität in Mainz, Germany, and completed his residency at Duke University School of Medicine. He has a strong research interest in immunologic and genomic profiling and has presented his findings at numerous national and international conferences. Dr. Seiwert is highly respected in the field of oncology and has received multiple awards for his contributions to cancer research. Patients can expect top-notch care and expertise when visiting Dr. Tanguy Lim-Seiwert at his practice in Baltimore. Please note that due to the recent collapse of the Francis Scott Key Bridge, there may be delays when traveling to appointments in the Baltimore region. Additionally, masks are strongly recommended but not required in Maryland clinical locations.

Patrick Forde is a doctor specializing in the treatment of lung cancer, mesothelioma, and other thoracic cancers. Located at 201 North Broadway in Baltimore, Maryland, United States, Dr. Forde completed his training in internal medicine and oncology in Ireland before joining Johns Hopkins. As the Co-Director of the Division of Upper Aerodigestive Malignancies in the Department of Oncology, he leads the multidisciplinary Thoracic Oncology Clinical Research Program. Dr. Forde's research focuses on immuno-oncology for upper aerodigestive malignancies, leading to the development of several ongoing phase 3 trials. His work has been instrumental in the FDA approval of neoadjuvant chemo-immunotherapy for surgically operable lung cancer. Patients can expect compassionate care from Dr. Forde and his team of oncology specialists. Please note that due to the recent collapse of the Francis Scott Key Bridge, there may be delays when traveling to appointments. Masks are strongly recommended but not required in Maryland clinical locations.

Dr. Marina Baretti is an esteemed oncologist located at 201 North Broadway in Baltimore, Maryland. Specializing in the care of gastrointestinal (GI) cancer patients, Dr. Baretti is known for her expertise in translational research and her collaboration with laboratory-based researchers to bring novel compounds to the clinic. With a focus on hepatobiliary cancer and the impact of epigenetic therapies as immune sensitizers, Dr. Baretti has achieved remarkable success in her field. Having completed her medical training at prestigious institutions in Italy and Johns Hopkins University School of Medicine, Dr. Baretti brings a wealth of knowledge and experience to her practice. She has received accolades such as the American Society of Clinical Oncology Young Investigator Award and the Career Development Award for MD Anderson Cancer Center's pancreatic cancer NCI Specialized Programs of Research Excellence (SPORE).

Gabriel Ghiaur, MD is a doctor specializing in leukemia, bone marrow transplant, hematologic malignancies, and natural killer cells. Located at 1800 Orleans Street in Baltimore, Maryland, United States, Dr. Ghiaur is a member of the Johns Hopkins Kimmel Cancer Center. His research focuses on normal and malignant hematopoiesis, specifically the role of the microenvironment in cell extrinsic drug resistance and minimal residual disease. With translational potential in stem cell therapeutics, acute leukemia, and multiple myeloma, Dr. Ghiaur is known for his outstanding laboratory-based investigations and superior clinical skills. Patients are encouraged to anticipate delays when traveling to appointments in the Baltimore region due to the collapse of the Francis Scott Key Bridge. Masks are strongly recommended but not required at Johns Hopkins Medicine clinical locations in Maryland. Dr. Ghiaur's commitment to patient care and cutting-edge research makes him a trusted healthcare provider for those seeking treatment for hematologic conditions.

Kristen Marrone is a doctor specializing in thoracic medical oncology located at 300 Mason Lord Drive in Baltimore, Maryland. She is dedicated to caring for patients with lung cancer and esophageal cancer. Dr. Marrone is also the Program Director of the Hematology/Medical Oncology Fellowship Program at the Johns Hopkins School of Medicine. Her research interests include clinical trial development and translational studies focusing on optimizing immunotherapy in oncogene-driven non-small cell lung cancer. She is a member of several prestigious medical organizations including the American Association of Cancer Research and the American Society of Clinical Oncology. Patients have rated Dr. Marrone highly for her compassionate care and expertise in the field. Due to recent transportation issues in the Baltimore region, please plan for potential delays when traveling to appointments. Masks are strongly recommended but not required in Maryland clinical locations.

Tania Jain is a doctor specializing in hematological malignancies and stem cell transplantation, located at 401 North Broadway, Baltimore, Maryland, United States. Due to the recent collapse of the Francis Scott Key Bridge, there may be delays when traveling to appointments. Masks are strongly recommended but not required in Maryland. Dr. Jain's research focuses on cellular therapy for hematological malignancies, with a particular interest in preventing relapse following stem cell transplantation. She also directs the adult CAR T program for hematological malignancies. Dr. Jain has published research on factors predicting survival outcomes in patients with myelofibrosis and on the safety and feasibility of CAR T cell therapy after transplantation. Patients rate Dr. Jain highly on the national CG-CAHPS Medical Practice patient experience survey.

Dr. Patrick Forde is a renowned doctor specializing in the treatment of lung cancer, mesothelioma, and other thoracic cancers. Located at 4940 Eastern Avenue in Baltimore, Maryland, United States, Dr. Forde completed his training in internal medicine and oncology in Ireland before joining Johns Hopkins Medicine. As the Co-Director of the Division of Upper Aerodigestive Malignancies in the Department of Oncology at Johns Hopkins, Dr. Forde leads the multidisciplinary Thoracic Oncology Clinical Research Program. His research focuses on immuno-oncology and has led to the development of several ongoing phase 3 clinical trials. Notably, his work on neoadjuvant chemo-immunotherapy for lung cancer was published in the New England Journal of Medicine and led to FDA approval. Patients visiting Dr. Forde can expect compassionate, state-of-the-art care from him and his team of oncology specialists. Despite recent traffic delays in the Baltimore region, patients are encouraged to prioritize their health and attend their appointments at Dr. Forde's institution. While masks are strongly recommended but not required in Maryland, the safety and well-being of patients remain a top priority at this health institution.